Evaluation of Corneal Collagen Shields as a Drug Delivery Device for the Treatment of Experimental Pseudomonas Keratitis
- 1 June 1992
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 99 (6) , 889-892
- https://doi.org/10.1016/s0161-6420(92)31877-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Device Drug Delivery to the EyeOphthalmology, 1991
- Collagen shield delivery of trifluorothymidineJournal of Cataract & Refractive Surgery, 1990
- Collagen Shield Delivery of Amphotericin BAmerican Journal of Ophthalmology, 1990
- Collagen corneal shields enhance penetration of topical prednisolone acetateJournal of Cataract & Refractive Surgery, 1989
- Collagen Shield Enhancement of Topical Dexamethasone PenetrationArchives of Ophthalmology (1950), 1989
- Treatment of Experimental Pseudomonas Keratitis Using Collagen Shields Containing TobramycinArchives of Ophthalmology (1950), 1988
- Collagen-Shield Delivery of Gentamicin and VancomycinArchives of Ophthalmology (1950), 1988
- Use of collagen corneal shields in the treatment of bacterial keratitis1American Journal of Ophthalmology, 1988
- Use of collagen corneal shields versus soft contact lenses to enhance penetration of topical tobramycinJournal of Cataract & Refractive Surgery, 1988
- Collagen shield drug delivery: Therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humorJournal of Cataract & Refractive Surgery, 1988